spacer
home > pmps > summer 2019 > the future of clinical trial design
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Future of Clinical Trial Design

A growing focus on new treatments for rare diseases and the proliferation of more personalised approaches to oncological drugs have changed the clinical trials landscape drastically. Ongoing technological advancements are also driving changes in how clinical trials are managed and how the necessary drug supply is developed, manufactured, and packaged.

These trends have coincided with a growing public awareness and pressure around the cost implications of getting a new drug to market; a common estimate is £1.5 billion, but some experts place it higher. If a drug fails towards the later stages of a clinical trial, the impact on the sponsor and its suppliers is often catastrophic.

The response is that companies throughout the clinical supply chain are looking to create efficiency and reduce overall costs. Many are seeking to automate processes wherever possible – both in production and trial management – to meet the demand for improved productivity while maintaining high-quality results.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Based in Rhymney, South Wales, Dave Wilson is Head of Operations at Sharp Clinical Services. Dave began with Sharp in May 2016 and has over 18 years of end-toend fast-moving consumer goods operations management experience, including project management, planning, warehousing, despatch, and transport. Prior to joining Sharp, Dave worked as Operations Director at Amcor Flexibles and has previously worked for Unilever and Reckitt Benckiser.

Based in Bethlehem, US, John Morrison is General Manager at Sharp Clinical Services US. John is an economics graduate with over 26 years’ experience in the clinical trial packaging and logistics market. Before joining the company, he was General Manager of Clinical US Operations at Catalent Pharma Solutions, where he was responsible for significant growth in both revenue and operating profits.
spacer
Dave Wilson
spacer
spacer
spacer
John Morrison
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement